Altered functionality in rhodopsin point mutants associated with retinitis pigmentosa

被引:31
作者
Andrés, A
Garriga, P [1 ]
Manyosa, J
机构
[1] Univ Politecn Catalunya, Escola Opt & Optometria, Dept Engn Quim, Catalonia, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Biofis, Catalonia 08193, Spain
关键词
G-protein-coupled receptor; protein misfolding; transducin activation; retinitis pigmentosa;
D O I
10.1016/S0006-291X(03)00328-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Point mutations found in rhodopsin associated with the retinal degenerative disease retinitis pigmentosa have been expressed in mammalian COS-1 cells, purified, and characterised. The mutations characterised-most of them for the first time-have been Met44Thr, Gly114Asp, Arg135Leu, Val137Met, and Prol71Leu in the transmembrane domain; Leu328Pro and Ala346Pro in the C-terminal tail of the cytoplasmic domain; and Gly106Trp in the intradiscal domain. Several of these mutations cause misfolding which results in impaired 11-cis-retinal binding. Two of them, Met44Thr and Val137Met, show spectral and structural features similar to those of wild type rhodopsin (Type I mutants) but significantly increased transducin initial activation rates. We propose that, in the case of these mutants, abnormal functioning resulting in faster activation kinetics could also play a role in retinitis pigmentosa by altering the stoichiometric balance of the different proteins involved in the phototransduction biochemical reactions. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 51 条
[11]   The carboxyl-terminal domain is essential for rhodopsin transport in rod photoreceptors [J].
Concepcion, F ;
Mendez, A ;
Chen, J .
VISION RESEARCH, 2002, 42 (04) :417-426
[12]   7-HELIX RECEPTORS - STRUCTURE AND MODELING [J].
DONNELLY, D ;
FINDLAY, JBC .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (04) :582-589
[13]  
Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770
[14]   On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention [J].
Farrar, GJ ;
Kenna, PF ;
Humphries, P .
EMBO JOURNAL, 2002, 21 (05) :857-864
[15]   Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin [J].
Farrens, DL ;
Altenbach, C ;
Yang, K ;
Hubbell, WL ;
Khorana, HG .
SCIENCE, 1996, 274 (5288) :768-770
[16]   TOTAL SYNTHESIS OF A GENE FOR BOVINE RHODOPSIN [J].
FERRETTI, L ;
KARNIK, SS ;
KHORANA, HG ;
NASSAL, M ;
OPRIAN, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (03) :599-603
[17]  
FRANKE RR, 1988, J BIOL CHEM, V263, P2119
[18]   RHODOPSIN MUTANTS THAT BIND BUT FAIL TO ACTIVATE TRANSDUCIN [J].
FRANKE, RR ;
KONIG, B ;
SAKMAR, TP ;
KHORANA, HG ;
HOFMANN, KP .
SCIENCE, 1990, 250 (4977) :123-125
[19]   The eye photoreceptor protein rhodopsin. Structural implications for retinal disease [J].
Garriga, P ;
Manyosa, J .
FEBS LETTERS, 2002, 528 (1-3) :17-22
[20]   Structure and function in rhodopsin: Correct folding and misfolding in point mutants at and in proximity to the site of the retinitis pigmentosa mutation Leu-125->Arg in the transmembrane helix C [J].
Garriga, P ;
Liu, X ;
Khorana, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) :4560-4564